Overview of covid-19 in rural livelihood in Pakistan: its origin, transmission, symptoms, treatment

Farhana Nosheen, Nazia Malik, Anam Afzal, Waseem Nawaz


About 138 million population live in rural areas of Pakistan. Evidence confirmed that COVID-19 cases were found in rural areas of Pakistan distinctively. Vaccination is the best protection against the virus. In this paper, the main determinants, characteristics, safety precautions, and current statistics related to COVID-19 in rural areas of Pakistan are presented. This study focuses on a rural population that is highly susceptible to COVID-19 and has a relatively high fatality rate in recent months due to closer contact with humans, pets, and animals. Measures to prevent transmission of COVID-19 were very successful for younger and older aged people in Pakistan. The majority of patients with COVID-19 typically initially had a sore throat, cough, pneumonia, diarrhea, and fever. The situation in Pakistan remained in control as compared to the rest of the whole world. Additionally, after a long lockdown, the second and third wave of COVID-19 also had fewer effects on the Pakistan population compared to many other countries. The best cure for the COVID-19 infection should be vaccinated and also focused on personal care, hygiene, take ample sunlight, fresh air, and ensure personal protection as well as social distancing. Moreover, the Pakistan government should provide guidelines and training to healthcare workers, and safety essentials to be imposed on people who violate standard operating procedure (SOPs) like levied penalties, sealing shops, send to jails, etc. Additionally, now that the vaccine has been introduced, adaptations to COVID-19 safety restrictions should be made and include mandatory vaccination as well as precautionary measures for all citizens.


SARS-CoV-2; COVID-19; Transmission; Symptoms; Treatment; Vaccination; Personal hygiene


Bassetti, M., A. Vena and D. R. Giacobbe. 2020. The novel Chinese coronavirus (2019-nCoV) infections: Challenges for fighting the storm. European journal of clinical investigation, 50: e13209-e09.

Bogoch, I. I., A. Watts, A. Thomas-Bachli, C. Huber, M. U. G. Kraemer and K. Khan. 2020. Pneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travel. Journal of travel medicine, 27: taaa008.

Chan, J. F.-W., K.-H. Kok, Z. Zhu, H. Chu, K. K.-W. To, S. Yuan and K.-Y. Yuen. 2020. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerging microbes & infections, 9: 221-36.

Chen, N., M. Zhou, X. Dong, J. Qu, F. Gong, Y. Han, Y. Qiu, J. Wang, Y. Liu, Y. Wei, J. a. Xia, T. Yu, X. Zhang and L. Zhang. 2020.

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet (London, England), 395: 507-13.

Corneli, H. M., J. J. Zorc, P. Mahajan, K. N. Shaw, R. Holubkov, S. D. Reeves, R. M. Ruddy, B. Malik, K. A. Nelson, J. S. Bregstein, K. M. Brown, M. N. Denenberg, K. A. Lillis, L. B. Cimpello, J. W. Tsung, D. A. Borgialli, M. N. Baskin, G. Teshome, M. A. Goldstein, D. Monroe, J. M. Dean and N. Kuppermann. 2007. A Multicenter, Randomized, Controlled Trial of Dexamethasone for Bronchiolitis. New England Journal of Medicine, 357: 331-39.

Gorbalenya, A. E., S. C. Baker, R. S. Baric, R. J. de Groot, C. Drosten, A. A. Gulyaeva, B. L. Haagmans, C. Lauber, A. M. Leontovich and B. W. Neuman. 2020. Severe acute respiratory syndrome-related coronavirus: The species and its viruses–a statement of the Coronavirus Study Group. BioRxiv.

Guan, W.-j., Z.-y. Ni, Y. Hu, W.-h. Liang, C.-q. Ou, J.-x. He, L. Liu, H. Shan, C.-l. Lei and D. S. Hui. 2020. Clinical characteristics of 2019 novel coronavirus infection in China. MedRxiv.

Huang, C., Y. Wang, X. Li, L. Ren, J. Zhao, Y. Hu, L. Zhang, G. Fan, J. Xu, X. Gu, Z. Cheng, T. Yu, J. Xia, Y. Wei, W. Wu, X. Xie, W. Yin, H. Li, M. Liu, Y. Xiao, H. Gao, L. Guo, J. Xie, G. Wang, R. Jiang, Z. Gao, Q. Jin, J. Wang and B. Cao. 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England), 395: 497-506.

Jaimes, J. A., J. K. Millet, A. E. Stout, N. M. André and G. R. Whittaker. 2020. A Tale of Two Viruses: The Distinct Spike Glycoproteins of Feline Coronaviruses. Viruses, 12: 83.

Ji, W., W. Wang, X. Zhao, J. Zai and X. Li. 2020. Cross-species transmission of the newly identified coronavirus 2019-nCoV. Journal of medical virology, 92: 433-40.

Lei, J., J. Li, X. Li and X. Qi. 2020. CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia. Radiology, 295: 18-18.

Li, G., Y. Fan, Y. Lai, T. Han, Z. Li, P. Zhou, P. Pan, W. Wang, D. Hu, X. Liu, Q. Zhang and J. Wu. 2020. Coronavirus infections and immune responses. Journal of medical virology, 92: 424-32.

Lu, H., C. W. Stratton and Y.-W. Tang. 2020. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. Journal of medical virology, 92: 401-02.

Lu, R., X. Zhao, J. Li, P. Niu, B. Yang, H. Wu, W. Wang, H. Song, B. Huang, N. Zhu, Y. Bi, X. Ma, F. Zhan, L. Wang, T. Hu, H. Zhou, Z. Hu, W. Zhou, L. Zhao, J. Chen, Y. Meng, J. Wang, Y. Lin, J. Yuan, Z. Xie, J. Ma, W. J. Liu, D. Wang, W. Xu, E. C. Holmes, G. F. Gao, G. Wu, W. Chen, W. Shi and W.

Tan. 2020. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet (London, England), 395: 565-74.

Ni, Y.-N., G. Chen, J. Sun, B.-M. Liang and Z.-A. Liang. 2019. The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis. Critical care (London, England), 23: 99-99.

Ren, L.-L., Y.-M. Wang, Z.-Q. Wu, Z.-C. Xiang, L. Guo, T. Xu, Y.-Z. Jiang, Y. Xiong, Y.-J. Li, X.-W. Li, H. Li, G.-H. Fan, X.-Y. Gu, Y. Xiao, H. Gao, J.-Y. Xu, F. Yang, X.-M. Wang, C. Wu, L. Chen, Y.-W. Liu, B. Liu, J. Yang, X.-R. Wang, J. Dong, L. Li, C.-L. Huang, J.-P. Zhao, Y. Hu, Z.-S. Cheng, L.-L. Liu, Z.-H. Qian, C. Qin, Q. Jin, B. Cao and J.-W. Wang. 2020. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chinese medical journal, 133: 1015-24.

Russell, C. D., J. E. Millar and J. K. Baillie. 2020. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet (London, England), 395: 473-75.

Wan, Y., J. Shang, R. Graham, R. S. Baric and F. Li. 2020. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. Journal of virology, 94: e00127-20.

Wang, M., R. Cao, L. Zhang, X. Yang, J. Liu, M. Xu, Z. Shi, Z. Hu, W. Zhong and G. Xiao. 2020. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell research, 30: 269-71.

Wang, W., T. Jianming and W. Fangqiang. 2020. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. Journal of medical virology, 92: 441-47.

Full Text: PDF

DOI: 10.33687/ijae.009.03.3507


  • There are currently no refbacks.

Copyright (c) 2021 Farhana Nosheen

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.